Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FSMA Import Requirements Could Reach Port Before Many Firms Prepare

This article was originally published in The Tan Sheet

Executive Summary

Supplement importers should review their supply chains and records maintenance to ensure FSVP compliance, though those and other actions are necessary for ongoing supply chain integrity. Still, many small and medium-sized businesses are unprepared, says regulatory consultant David Acheson.

You may also be interested in...

HBW Market Roundup: Prop 65 Amendment Off, Enforcement Discretion Asked For Label Compliance, More

California withdraws Prop 65 proposal to clarify when and how average concentrations can be calculated for a listed chemical due to deadline; trade groups ask FDA for enforcement discretion on compliance date for Nutrition and Supplement Facts labels rules; FDA published list of necessary records for FSVP applications; and use of OTC analgesics grows in teen suicide attempts.

Foreign Supplier Verification Concerns Grow On Supplement Firms

Supplement firms are making business decisions to avoid high costs linked to possible designation as importers under the FSMA foreign supplier verification program.

FSMA Supplier Verification Rule Affects Finished Supplement Importers

Proposed FSMA rules would subject imported food products, including supplements, to the same safety standards as domestically produced food. The proposals are reminders that although supplement manufacturing is exempt from FSMA provisions redundant to GMP requirements, the act adds regulatory burdens for some firms.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts